Skip to main content
Clinical Trials/NCT06350305
NCT06350305
Not yet recruiting
Not Applicable

Screening Study at High-risk Chronic Obstructive Pulmonary Disease

Henan University of Traditional Chinese Medicine1 site in 1 country3,600 target enrollmentMay 1, 2024
ConditionsHigh-risk COPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
High-risk COPD
Sponsor
Henan University of Traditional Chinese Medicine
Enrollment
3600
Locations
1
Primary Endpoint
COPD screening questionnaire from Terrassa (EGARPOC)
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).

Detailed Description

Targeting high-risk populations for chronic obstructive pulmonary disease (COPD), targeted at key issues such as unclear risk factors and lack of prevention and treatment plans, high-risk population screening was conducted to identify risk factors. This study is expected to detect at least 3600 high-risk individuals with early-stage chronic obstructive pulmonary disease. The incidence rate of high-risk individuals in the early stage of chronic obstructive pulmonary disease is 30%, which means the total screening population is 12000 cases.

Registry
clinicaltrials.gov
Start Date
May 1, 2024
End Date
October 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Henan University of Traditional Chinese Medicine
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • According to the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021), a multi-stage cluster random sampling method was used to select individuals from representative administrative villages with a history of chronic cough or sputum production, breathing difficulties, recurrent lower respiratory tract infections, and/or exposure to potential risk factors for chronic obstructive pulmonary disease.
  • The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.

Exclusion Criteria

  • Patients who are delirious, have impaired consciousness, dementia, various psychiatric disorders, etc., and cannot be accurately informed of their basic physical condition.
  • Patients who, in the opinion of the investigator, are not suitable for participation in this study.

Outcomes

Primary Outcomes

COPD screening questionnaire from Terrassa (EGARPOC)

Time Frame: During screening

3-29 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥13, the participant needed to be seen by a physician for further testing to determine if they had COPD.

COPD screening questionnaire (COPD-Q)

Time Frame: During screening

0-10 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥4, the participant needed to be seen by a physician for further testing to determine if they had COPD.

lung function questionnaire (LFQ)

Time Frame: During screening

5-25 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≤18, the participant needed to be seen by a physician for further testing to determine if they had COPD.

Simple screening questionnaire

Time Frame: During screening

0-11 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥6, the participant needed to be seen by a physician for further testing to determine if they had COPD.

chronic obstructive pulmonary disease population screener questionnaire (COPD-PS)

Time Frame: During screening

0-10 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥5, the participant needed to be seen by a physician for further testing to determine if they had COPD.

COPD assessment in primary care to identify undiagnosed respiratory disease and exacerbation risk questionnaire (CAPTURE)

Time Frame: During screening

0-6 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥2, the participant needed to be seen by a physician for further testing to determine if they had COPD.

chronic obstructive pulmonary disease diagnostic questionnaire (CDQ)

Time Frame: During screening

0-38 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥17, the participant needed to be seen by a physician for further testing to determine if they had COPD.

chronic obstructive pulmonary disease screening questionnaire (COPD-SQ)

Time Frame: During screening

0-38 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥16, the participant needed to be seen by a physician for further testing to determine if they had COPD.

Syndrome therapeutic evaluation scale of chronic obstructive pulmonary disease (COPD-STES)

Time Frame: During screening

Subjects should fill in the relevant entries truthfully according to the category of symptoms as judged by the doctor and tick the appropriate box. Among them, the part of tongue and pulse should be filled in by the doctor.

COPD Assessment Test (CAT)

Time Frame: During screening

0-40 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was \>10, the participant needed to be seen by a physician for further testing to determine if they had COPD.

modified chronic obstructive pulmonary disease diagnostic questionnaire (mCDQ)

Time Frame: During screening

0-45 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥18, the participant needed to be seen by a physician for further testing to determine if they had COPD.

Chronic Obstructive Pulmonary Disease Risk Scale (COPDRS)

Time Frame: During screening

0-9 scores. Scores for each questionnaire item were tallied based on the participant's responses, and if the total score was ≥5, the participant needed to be seen by a physician for further testing to determine if they had COPD.

Standardised Scale of Physical Fitness in Chinese Medicine

Time Frame: During screening

Answer all the questions in the Classification and Determination of Physical Qualities in Chinese Medicine Table. Each question is rated on a 5-point scale, and the raw and transformed scores are calculated to determine the type of physical qualities according to the criteria. Raw score = sum of the scores of each entry. Transformation score = \[(raw score - number of entries)/(number of entries × 4)\] × 100.

Study Sites (1)

Loading locations...

Similar Trials